🇺🇸 Clonidine Pill in United States

8 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

• Window: 22 April 2025 – 22 April 2026
• Total reports: 8

Most-reported reactions

1. Application Site Erythema — 1 report (12.5%)
2. Application Site Pruritus — 1 report (12.5%)
3. Application Site Rash — 1 report (12.5%)
4. Blood Pressure Increased — 1 report (12.5%)
5. Fatigue — 1 report (12.5%)
6. Pollakiuria — 1 report (12.5%)
7. Sleep Disorder — 1 report (12.5%)
8. Urticaria — 1 report (12.5%)

Source database →

Frequently asked questions

Is Clonidine Pill approved in United States?

Clonidine Pill does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for Clonidine Pill in United States?

Weill Medical College of Cornell University is the originator. The local marketing authorisation holder may differ — check the official source linked above.